Reinsurance Group of America (RGA)
Official siteFINANCIAL SERVICES • INSURANCE - REINSURANCE • NYSE
Market Cap: $17.90B
Last updated: Nov 17, 2026 at 11:05 AM ET
Reinsurance Group of America (RGA) Earnings: Report Dates and Results
Reinsurance Group of America (RGA) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Reinsurance Group of America reported EPS of $8.49, above the $6.98 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RGA has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.1% below the $7.75 reported for the quarter ended Dec 31, 2025.
RGA Earnings Call
The latest RGA earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, RGA beat 24, missed 15 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $7.45B, up 21.9% from $6.11B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $8.49 | $6.98 | $6.66 - $7.23 | +21.63% | Beat | +82.2% | 10 | 4 up, 1 down | Nov 5, 2026 | $7.45B |
| Jun 30, 2026 | $8.89 | $6.51 | $6.36 - $6.61 | +36.56% | Beat | +88.3% | 10 | 2 up, 5 down | Aug 6, 2026 | $6.54B |
| Mar 31, 2026 | $6.97 | $6.01 | $5.18 - $6.31 | +15.97% | Beat | +23.1% | 10 | 1 up, 2 down | May 7, 2026 | $6.39B |
| Dec 31, 2025 | $7.75 | $5.75 | $5.49 - $6.16 | +34.78% | Beat | +55.3% | 10 | 2 up, 2 down | Feb 5, 2026 | $6.54B |
| Sep 30, 2025 | $4.66 | $5.77 | $5.53 - $5.98 | -19.24% | Miss | -24.0% | 11 | 5 up, 3 down | Oct 30, 2025 | $6.11B |
| Jun 30, 2025 | $4.72 | $5.55 | $5.36 - $5.88 | -14.96% | Miss | -13.9% | 10 | 4 up, 3 down | Jul 31, 2025 | $5.51B |
| Mar 31, 2025 | $5.66 | $5.34 | $5.10 - $5.76 | +5.99% | Beat | -6.0% | 9 | 2 up, 6 down | May 1, 2025 | $5.18B |
| Dec 31, 2024 | $4.99 | $5.26 | $5.03 - $5.59 | -5.13% | Miss | +5.5% | 11 | 6 up, 1 down | Feb 6, 2025 | $5.16B |
| Sep 30, 2024 | $6.13 | $5.34 | $4.94 - $5.96 | +14.79% | Beat | +10.1% | 13 | 4 up, 0 down | Oct 31, 2024 | $5.57B |
| Jun 30, 2024 | $5.48 | $5.09 | $4.61 - $5.55 | +7.66% | Beat | +24.5% | 12 | 4 up, 0 down | Aug 1, 2024 | $4.81B |
| Mar 31, 2024 | $6.02 | $4.57 | $4.25 - $4.70 | +31.73% | Beat | +16.7% | 11 | 4 up, 1 down | May 2, 2024 | $6.27B |
| Dec 31, 2023 | $4.73 | $4.46 | $4.18 - $4.83 | +6.05% | Beat | +58.2% | 13 | 1 up, 0 down | Feb 1, 2024 | $4.94B |
| Sep 30, 2023 | $5.57 | $4.28 | $4.13 - $4.50 | +30.14% | Beat | +7.1% | 12 | 2 up, 1 down | Nov 2, 2023 | $5.08B |
| Jun 30, 2023 | $4.40 | $4.14 | $3.91 - $4.40 | +6.28% | Beat | -23.9% | 13 | 4 up, 0 down | Aug 3, 2023 | $4.09B |
| Mar 31, 2023 | $5.16 | $3.35 | $3.00 - $3.76 | +54.03% | Beat | +997.9% | 13 | 8 up, 0 down | May 4, 2023 | $4.20B |
| Dec 31, 2022 | $2.99 | $3.73 | $3.01 - $4.33 | -19.84% | Miss | N/A | 12 | 3 up, 0 down | Feb 2, 2023 | $4.30B |
| Sep 30, 2022 | $5.20 | $3.00 | $2.60 - $3.29 | +73.33% | Beat | N/A | 12 | 2 up, 1 down | Nov 3, 2022 | $4.00B |
| Jun 30, 2022 | $5.78 | $2.76 | N/A | +109.42% | Beat | +44.5% | N/A | 3 up, 0 down | Aug 4, 2022 | $3.86B |
| Mar 31, 2022 | $0.47 | -$0.48 | -$1.53 - $0.81 | +197.92% | Beat | N/A | 11 | 1 up, 0 down | May 5, 2022 | $3.88B |
| Dec 31, 2021 | -$0.56 | $0.79 | -$0.35 - $1.75 | -170.89% | Miss | -147.1% | 11 | N/A | Feb 3, 2022 | $4.36B |
| Sep 30, 2021 | -$1.11 | $2.46 | $1.63 - $3.23 | -145.12% | Miss | -131.6% | 9 | N/A | Nov 4, 2021 | $4.00B |
| Jun 30, 2021 | $4.00 | $1.96 | $1.33 - $2.64 | +104.08% | Beat | +194.1% | 10 | N/A | Aug 3, 2021 | $4.09B |
| Mar 31, 2021 | -$1.24 | -$0.33 | -$1.00 - $0.41 | -275.76% | Miss | -187.9% | 10 | N/A | May 6, 2021 | $4.07B |
| Dec 31, 2020 | $1.19 | $1.02 | $0.50 - $1.90 | +16.67% | Beat | -65.3% | 10 | N/A | Feb 8, 2021 | $4.20B |
| Sep 30, 2020 | $3.51 | $1.77 | $1.00 - $2.28 | +98.31% | Beat | -12.7% | 10 | N/A | Nov 5, 2020 | $3.53B |
| Jun 30, 2020 | $1.36 | -$0.85 | -$1.81 - -$0.09 | +260.00% | Beat | -58.9% | 10 | N/A | Aug 4, 2020 | $3.56B |
| Mar 31, 2020 | $1.41 | $2.37 | $2.05 - $2.68 | -40.51% | Miss | -46.0% | 10 | N/A | May 5, 2020 | $3.13B |
| Dec 31, 2019 | $3.43 | $3.66 | $3.56 - $3.75 | -6.28% | Miss | -0.9% | 10 | N/A | Jan 28, 2020 | $3.74B |
| Sep 30, 2019 | $4.02 | $3.50 | $3.34 - $3.62 | +14.86% | Beat | -0.2% | 10 | N/A | Oct 30, 2019 | $3.58B |
| Jun 30, 2019 | $3.31 | $3.42 | $3.31 - $3.74 | -3.22% | Miss | +6.8% | 10 | N/A | Jul 29, 2019 | $3.42B |
| Mar 31, 2019 | $2.61 | $2.62 | $1.91 - $2.80 | -0.38% | Miss | +62.1% | 10 | N/A | Apr 29, 2019 | $3.38B |
| Dec 31, 2018 | $3.46 | $3.46 | $3.34 - $3.65 | 0.00% | In line | +33.1% | 10 | N/A | Jan 28, 2019 | $3.24B |
| Sep 30, 2018 | $4.03 | $3.27 | $3.16 - $3.42 | +23.24% | Beat | +17.2% | 10 | N/A | Oct 25, 2018 | $3.19B |
| Jun 30, 2018 | $3.10 | $3.11 | $3.06 - $3.30 | -0.32% | Miss | +5.1% | 9 | N/A | Jul 26, 2018 | $3.16B |
| Mar 31, 2018 | $1.61 | $2.44 | $2.26 - $2.87 | -34.02% | Miss | -13.4% | 10 | N/A | Apr 26, 2018 | $3.14B |
| Dec 31, 2017 | $2.60 | $2.84 | $2.80 - $2.93 | -8.45% | Miss | -1.1% | 9 | N/A | Jan 29, 2018 | $3.20B |
| Sep 30, 2017 | $3.44 | $2.63 | $2.52 - $2.72 | +30.80% | Beat | +39.8% | 8 | N/A | Oct 26, 2017 | $3.11B |
| Jun 30, 2017 | $2.95 | $2.48 | $2.33 - $2.55 | +18.95% | Beat | +5.4% | 9 | N/A | Jul 27, 2017 | $3.10B |
| Mar 31, 2017 | $1.86 | $2.14 | N/A | -13.08% | Miss | +0.5% | N/A | N/A | Apr 27, 2017 | $2.97B |
| Dec 31, 2016 | $2.63 | $2.53 | N/A | +3.95% | Beat | -7.4% | N/A | N/A | Jan 30, 2017 | $3.03B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $22.79, up 0.8% from the year before. It was $9.74 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $22.79 | +0.8% |
| Dec 31, 2024 | $22.62 | +13.9% |
| Dec 31, 2023 | $19.86 | +37.5% |
| Dec 31, 2022 | $14.44 | +1224.8% |
| Dec 31, 2021 | $1.09 | -85.4% |
| Dec 31, 2020 | $7.47 | -44.1% |
| Dec 31, 2019 | $13.37 | +9.6% |
| Dec 31, 2018 | $12.20 | +12.4% |
| Dec 31, 2017 | $10.85 | +11.4% |
| Dec 31, 2016 | $9.74 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,200 words across 12 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,230 | 12 | |
| 2026Q2 | Jun 30, 2026 | 5,624 | 12 | |
| 2026Q1 | Mar 31, 2026 | 5,401 | 11 | |
| 2025Q4 | Dec 31, 2025 | 6,551 | 14 | |
| 2025Q3 | Sep 30, 2025 | 5,999 | 13 | |
| 2025Q2 | Jun 30, 2025 | 8,072 | 15 | |
| 2025Q1 | Mar 31, 2025 | 8,369 | 17 | |
| 2024Q4 | Dec 31, 2024 | 8,511 | 15 |
2026Q3 Earnings Call
Opening remarks
Tony Cheng CEO Good morning, everyone, and thank you for joining us today. We appreciate your continued interest in RGA. I am pleased to share that we delivered excellent results this quarter, with strong performance across all regions. Investment performance was robust, and economic claims experience was favorable to expectations, demonstrating our success on both sides of the balance sheet. These results were another proof point on the importance of our strategy and core differentiators: deep biometric expertise, strong asset management capabilities, a global platform of local offices, a market-leading brand, and flexibility to partner across the industry. They also demonstrate our ability to generate attractive risk-adjusted returns across a range of market environments. With this strong foundation in place, our priorities moving forward remain clear: deliver attractive, sustainable returns, manage risk well, and deploy capital where we see the best long-term value. Before I turn to the results, let me highlight three items from the quarter and how they tie to our strategy. First, our pipeline for both in-force and flow business remains attractive. This quarter, the U.S. PRT and U.K. longevity markets picked up after a slow start to the year. We were active in both, completing several transactions, and we are encouraged by the outlook for the fourth quarter and into 2027. Beyond these two markets, our other business segments continued to benefit from attractive opportunities, building on our strong market presence. Second, a key element of our biometric risk expertise is the rigor of our assumption-setting process. This quarter, we completed our annual assumption review. This resulted in no net impact on consolidated pretax adjusted operating income. The completion of the review gives us added confidence in both our in-force business and the new business we are writing. Finally, third-party capital remains a core element of our capital management strategy. These structures provide an opportunity for third-party investors to participate in the returns of our business while generating incremental fee income over time and enhancing our flexibility to fund growth and return capital to shareholders. In the quarter, I'm very pleased that we showed the continued execution of this strategy with the full deployment of Ruby Re capital. Turning now to the regional results. In the Americas, the results for the quarter were driven by strong investment income, sound underwriting experience, and the continued favorable impact of in-force actions executed in prior periods. New business momentum continued, and we were particularly pleased with the completion of four pension risk transfer transactions totaling over $800 million in combined premium. The overall pipeline for the region is encouraging, and we are seeing a wide range of opportunities across the spectrum of underwriting, product development, and asset-intensive transactions with biometric risk.
Frequently Asked Questions About RGA
When is Reinsurance Group of America's next earnings date?
Reinsurance Group of America's next earnings report is expected for Feb 3, 2027.
Did RGA beat earnings estimates last quarter?
Yes. Reinsurance Group of America reported EPS of $8.49 for the quarter ended Sep 30, 2026, above the $6.98 estimate, a 21.63% surprise.
What EPS do analysts expect from RGA next quarter?
The consensus EPS estimate for Reinsurance Group of America for the quarter ending Dec 31, 2026 is $7.28 from 12 analysts, with estimates from $6.54 to $8.39.
How often does RGA beat earnings estimates?
Reinsurance Group of America beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +9.45%.
RGA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors